AstraZeneca PLC (AZNCF)

USD 129.58

(0.0%)

Inventory Summary of AstraZeneca PLC

  • AstraZeneca PLC's latest annual inventory in 2023 was 5.41 Billion USD , up 15.27% from previous year.
  • AstraZeneca PLC's latest quarterly inventory in 2024 Q2 was 5.66 Billion USD , up 6.26% from previous quarter.
  • AstraZeneca PLC reported annual inventory of 4.69 Billion USD in 2022, down -47.69% from previous year.
  • AstraZeneca PLC reported annual inventory of 8.98 Billion USD in 2021, up 123.24% from previous year.
  • AstraZeneca PLC reported quarterly inventory of 5.33 Billion USD for 2024 Q1, down -1.54% from previous quarter.
  • AstraZeneca PLC reported quarterly inventory of 5.05 Billion USD for 2023 Q2, up 1.69% from previous quarter.

Annual Inventory Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Inventory of AstraZeneca PLC (2023 - 1990)

Year Inventory Inventory Growth
2023 5.41 Billion USD 15.27%
2022 4.69 Billion USD -47.69%
2021 8.98 Billion USD 123.24%
2020 4.02 Billion USD 26.03%
2019 3.19 Billion USD 10.48%
2018 2.89 Billion USD -4.78%
2017 3.03 Billion USD 30.03%
2016 2.33 Billion USD 8.91%
2015 2.14 Billion USD 9.34%
2014 1.96 Billion USD 2.67%
2013 1.9 Billion USD -7.38%
2012 2.06 Billion USD 11.29%
2011 1.85 Billion USD 10.11%
2010 1.68 Billion USD -3.89%
2009 1.75 Billion USD 6.97%
2008 1.63 Billion USD -22.79%
2007 2.11 Billion USD -5.82%
2006 2.25 Billion USD 1.99%
2005 2.2 Billion USD -26.95%
2004 3.02 Billion USD -0.07%
2003 3.02 Billion USD 16.49%
2002 2.59 Billion USD -24.51%
2001 3.43 Billion USD 63.18%
2000 2.1 Billion USD -2.27%
1999 2.15 Billion USD 62.69%
1998 1.32 Billion USD 10.06%
1997 1.2 Billion USD 3.19%
1996 1.16 Billion USD -11.31%
1995 1.31 Billion USD 8.39%
1994 1.21 Billion USD 5.69%
1993 1.14 Billion USD -9.47%
1992 1.26 Billion USD -2.22%
1991 1.29 Billion USD -0.26%
1990 1.3 Billion USD 0.0%

Peer Inventory Comparison of AstraZeneca PLC

Name Inventory Inventory Difference
Bristol-Myers Squibb Company PFD CONV 2 2.66 Billion USD -103.469%
CSPC Pharmaceutical Group Limited 442.43 Million USD -1124.222%
Clarus Therapeutics Holdings, Inc. 14.21 Million USD -38005.68%
Novartis AG 5.91 Billion USD 8.399%
PT Kalbe Farma Tbk. 451.27 Million USD -1100.218%